GoodRx (GDRX) Competitors $4.44 -0.05 (-1.11%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends GDRX vs. ETSY, QXO, LYFT, NVEI, TNET, CARG, DXC, ALIT, CLVT, and PAYOShould you be buying GoodRx stock or one of its competitors? The main competitors of GoodRx include Etsy (ETSY), QXO (QXO), Lyft (LYFT), Nuvei (NVEI), TriNet Group (TNET), CarGurus (CARG), DXC Technology (DXC), Alight (ALIT), Clarivate (CLVT), and Payoneer Global (PAYO). These companies are all part of the "business services" industry. GoodRx vs. Etsy QXO Lyft Nuvei TriNet Group CarGurus DXC Technology Alight Clarivate Payoneer Global GoodRx (NASDAQ:GDRX) and Etsy (NASDAQ:ETSY) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, earnings, community ranking, media sentiment, institutional ownership, profitability and dividends. Does the media refer more to GDRX or ETSY? In the previous week, Etsy had 9 more articles in the media than GoodRx. MarketBeat recorded 19 mentions for Etsy and 10 mentions for GoodRx. Etsy's average media sentiment score of 0.48 beat GoodRx's score of -0.22 indicating that Etsy is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GoodRx 0 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 4 Negative mention(s) 0 Very Negative mention(s) Neutral Etsy 5 Very Positive mention(s) 4 Positive mention(s) 8 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more risk & volatility, GDRX or ETSY? GoodRx has a beta of 1.29, indicating that its share price is 29% more volatile than the S&P 500. Comparatively, Etsy has a beta of 1.99, indicating that its share price is 99% more volatile than the S&P 500. Does the MarketBeat Community prefer GDRX or ETSY? Etsy received 777 more outperform votes than GoodRx when rated by MarketBeat users. Likewise, 58.98% of users gave Etsy an outperform vote while only 38.89% of users gave GoodRx an outperform vote. CompanyUnderperformOutperformGoodRxOutperform Votes7038.89% Underperform Votes11061.11% EtsyOutperform Votes84758.98% Underperform Votes58941.02% Is GDRX or ETSY more profitable? Etsy has a net margin of 9.17% compared to GoodRx's net margin of -2.05%. GoodRx's return on equity of 5.35% beat Etsy's return on equity.Company Net Margins Return on Equity Return on Assets GoodRx-2.05% 5.35% 2.51% Etsy 9.17%-46.79%11.09% Which has better earnings and valuation, GDRX or ETSY? Etsy has higher revenue and earnings than GoodRx. GoodRx is trading at a lower price-to-earnings ratio than Etsy, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGoodRx$790.39M2.14-$8.87M-$0.03-148.00Etsy$2.80B2.28$307.57M$1.9628.98 Do institutionals & insiders have more ownership in GDRX or ETSY? 63.8% of GoodRx shares are owned by institutional investors. Comparatively, 99.5% of Etsy shares are owned by institutional investors. 4.2% of GoodRx shares are owned by insiders. Comparatively, 2.6% of Etsy shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Do analysts recommend GDRX or ETSY? GoodRx currently has a consensus target price of $8.37, indicating a potential upside of 88.44%. Etsy has a consensus target price of $63.17, indicating a potential upside of 11.20%. Given GoodRx's stronger consensus rating and higher possible upside, research analysts clearly believe GoodRx is more favorable than Etsy.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score GoodRx 1 Sell rating(s) 5 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 2.63Etsy 4 Sell rating(s) 13 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.20 SummaryEtsy beats GoodRx on 13 of the 18 factors compared between the two stocks. Ad DTIWhy I'm telling friends to avoid gold stocksBack in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."And if you’d like to get your hands on this, here you go, the complete breakdown. Get GoodRx News Delivered to You Automatically Sign up to receive the latest news and ratings for GDRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GDRX vs. The Competition Export to ExcelMetricGoodRxData processing & preparation IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.69B$4.34B$5.14B$9.08BDividend YieldN/A2.86%5.09%4.23%P/E Ratio-148.0032.9789.8217.18Price / Sales2.141,743.091,116.21116.95Price / Cash11.7733.4742.8937.86Price / Book2.306.124.784.78Net Income-$8.87M$44.01M$120.23M$225.60M7 Day Performance-5.73%-3.91%-1.92%-1.23%1 Month Performance3.50%5.05%11.49%3.36%1 Year Performance-31.27%15.86%30.57%16.60% GoodRx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GDRXGoodRx2.8178 of 5 stars$4.44-1.1%$8.37+88.4%-29.4%$1.69B$790.39M-148.00950Analyst ForecastHigh Trading VolumeETSYEtsy4.4563 of 5 stars$61.27+3.9%$63.17+3.1%-32.0%$6.89B$2.75B31.262,420QXOQXO1.6408 of 5 stars$16.55+2.5%N/AN/A$6.78B$54.52M-1.77195News CoverageLYFTLyft4.6851 of 5 stars$14.23+0.6%$17.77+24.9%-9.9%$5.90B$5.46B-88.382,945NVEINuvei1.5819 of 5 stars$33.99+0.0%$32.08-5.6%+33.1%$4.82B$1.19B226.602,202Positive NewsHigh Trading VolumeTNETTriNet Group4.4715 of 5 stars$95.02-0.4%$117.00+23.1%-25.0%$4.71B$4.97B18.313,600CARGCarGurus3.6005 of 5 stars$38.21+1.4%$37.86-0.9%+50.9%$3.96B$914.24M-81.891,343Insider TradePositive NewsDXCDXC Technology2.4309 of 5 stars$21.40-0.3%$20.89-2.4%-6.3%$3.87B$13.67B268.28130,000Options VolumeALITAlight3.3513 of 5 stars$7.09-1.0%$10.83+52.8%-16.0%$3.85B$3.41B-14.9218,000CLVTClarivate3.0641 of 5 stars$5.39+5.5%$7.10+31.7%-44.2%$3.83B$2.58B-2.7612,000Buyback AnnouncementPAYOPayoneer Global3.9414 of 5 stars$10.46+1.8%$11.36+8.6%+106.1%$3.73B$940.30M29.372,167 Related Companies and Tools Related Companies Etsy Competitors QXO Competitors Lyft Competitors Nuvei Competitors TriNet Group Competitors CarGurus Competitors DXC Technology Competitors Alight Competitors Clarivate Competitors Payoneer Global Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:GDRX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GoodRx Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GoodRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
